Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）

NCT07278674 is registered in ClinicalTrials.gov with Shanghai Children's Hospital as lead sponsor.

NCT NCT07278674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07278674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）
Lead sponsor
Shanghai Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 8, 2025
Completion date
October 31, 2029
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk neuroblastoma